Ibotta, the mobile shopping app whose users have earned more than $110 million in rewards on in-store purchases, today launched a brand-new way for consumers to discover great brands and earn rewards on mobile, in-app purchases. Through partnerships with mobile commerce leaders such as Boxed, Groupon, Hotels.com, and Jet, Ibotta will offer rewards to shoppers for ordering goods and services directly from their smartphones and tablets.
As part of this app-to-app marketplace, Ibotta, which already features an array of offers from leading brands and retailers for rewards on groceries, clothing, electronics, and other in-store items, will now feature a Mobile Apps category. Launch partners include leading mobile innovators Boxed, delivery.com, DoorDash, Drizly, Groupon, Hotels.com, Jet, and Spring.
To view the multimedia release go to:
http://www.multivu.com/players/English/7914451-ibotta-mobile-shopping-app-rewards/
The world is requiring more renewable sources of energy to meet its needs. With decades of expertise in feedstock, bioprocessing and biofuel production, DuPont has answered the call with a fully integrated process that converts biomass to cellulosic ethanol.
This farm-to-fuel system is applied in our Nevada, Iowa biorefinery, which will produce 30 million gallons of fuel-grade ethanol a year, with a licensing model that can be applied anywhere in the world. Learn more about how DuPont is reforming energy in Iowa, and around the globe:
http://ib-promo.dupont.com/reformenergy/
The following statement is being issued by Block & Leviton LLP, Finkelstein Thompson LLP and Green & Noblin PC regarding the Drywall Antitrust Litigation.
If you purchased Wallboard INDIRECTLY from one or more of the companies listed below, your rights may be affected by proposed Settlements
Proposed class settlements totaling $10.5 million have been reached with two Defendants in In re Domestic Drywall Antitrust Litigation, MDL No. 2437 and 13-MD-2437, pending in the U.S. District Court for the Eastern District of Pennsylvania.
If you purchased for end use wallboard manufactured and/or distributed by CertainTeed Gypsum, Inc., USG Corporation, United States Gypsum Company, New NGC, Inc., Lafarge North America, Inc., Eagle Materials, Inc., American Gypsum Company LLC, PABCO Building Products, LLC, TIN, Inc., or their subsidiaries (collectively, the “Defendants”), between January 1, 2012 and November 30, 2014, you may be a class member. “Wallboard” means paper-backed gypsum wallboard, also called drywall or plasterboard.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7449651-drywall-class-action-settlement/
The following statement is being issued by Block & Leviton LLP, Finkelstein Thompson LLP and Green & Noblin PC regarding the Drywall Antitrust Litigation.
If you purchased Wallboard INDIRECTLY from one or more of the companies listed below, your rights may be affected by proposed Settlements
A proposed class settlement totaling $5.2 million has been reached with a defendant in In re Domestic Drywall Antitrust Litigation, MDL No. 2437 and 13-MD-2437, pending in the U.S. District Court for the Eastern District of Pennsylvania.
To view the multimedia release go to:
http://www.multivu.com/players/English/7975351-drywall-class-action-settlement/
Vikes, Dance Fever, French Fries. The names might not be familiar to you, but chances are good your kids have heard of them. These are the street names for prescription drugs, and more and more teens are using them to get high.
Each year, nearly 2 million teens abuse prescription drugs. The new parent’s Prescription and Over-the-Counter Drug Guide from BeSmartBeWell.com and The Partnership at Drugfree.org breaks down the most commonly abused prescription and over-the-counter drugs in a simple-to-understand and interactive web page. Learn drugs’ “street” names, how kids are using them (inject, inhale, etc.), why they're dangerous and the warning signs of abuse.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/besmartbewell/50821/
Rowenta, maker of the revolutionary new air purifier the Intense Pure Air, is collaborating with renowned Environmental Toxicologist Dr. Noreen Khan-Mayberry (aka “The Tox Doc”), to help allergy sufferers better manage their symptoms. An estimated 50 million Americans are allergic to dust, dander, mold and mites, which can cause trouble breathing, excessive sneezing, eye irritation and coughing, amongst other ailments.
Seasonal allergies affect approximately 30% of U.S. residents and are worsening due to climate change, which is not only causing an increase in pollen levels, but also extending the length of pollen season. As such, allergy sufferers and people with asthma and other respiratory issues are at an even greater risk for heightened symptoms both indoors and outdoors.
To view the multimedia release go to:
http://www.multivu.com/players/English/7779051-rowenta-intense-allergen-air-purifier/
An estimated 102 million Americans have cholesterol levels that are considered borderline high-risk.1 This staggering fact makes lowering cholesterol one of the most imperative things to do to promote overall heart health. Unfortunately, too few people understand the essential steps in reaching this goal. Metamucil and Dr. Michael Roizen, Chairman of the Wellness Institute at Cleveland Clinic and host of the upcoming PBS series, “Younger You,” have joined to present the “Five Things Every American Needs to Do to Lower Their Cholesterol” to encourage Americans to lead a proactive lifestyle with small modifications and dietary changes.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/metamucil/48409/
The following statement is being issued by Jonathan Schochor, Chairman, Plaintiffs’ Steering Committee, regarding Jane Doe No. 1, et. al. v. Johns Hopkins Hospital, et al., No. 24-C-13-001041.
If you were a patient of, or were treated by Johns Hopkins Hospital gynecologist, Dr. Nikita Levy, you may be eligible for compensation from a class action Settlement
A $190 million dollar proposed Settlement has been reached that offers payments to eligible members of The Levy Settlement Class.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7281851-dr-nikita-levy-patients-class-action-settlement/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
